Health

Ph.D

Canada

Re-establishing self-tolerance by targeting MHC class II-restricted autoimmunity

Juvenile diabetes is an autoimmune disease resulting from an attack that destroys pancreatic cells that secrete insulin. Javier Clemente Casares is studying a therapeutic approach that could lead to a nanovaccine for the disease.

A nanovaccine for juvenile diabetes

To add or modify information on this page, please contact us at the following address: community.research@axa.com

Javier
CLEMENTE-CASARES

Institution

University of Calgary

Country

Canada

Nationality

Spanish